COMP <GO>
MTW vs TMO // EV/EBITDA & P/E VALUATION
Manitowoc Company Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MTW 1
— TMO 10
▲ EV/EBITDA & P/E VALUATION LEADER: MTW
LAST: $23.80 (+2.81%) • MKT CAP: $858.3M
valuation
9.1x
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
valuation
30.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTW VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTW | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 18.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.90% | 9.30% | -2.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 9.1x | 30.4x | -21.30 | MTW | /valuation <GO> |
| Free Cash Flow Yield | -1.78% | 2.40% | -4.18 | TMO | /fcf-yield <GO> |
| Operating Margin | 2.40% | 17.40% | -15.00 | TMO | /operating-margins <GO> |
| Net Profit Margin | 0.30% | 15.10% | -14.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.90% | 3.90% | -1.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 62.9 | -5.91 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 110.9x | 36.3x | +74.60 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $858.3M | $262.22B | -$261.36B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTW REV | TMO REV | MTW GROSS % | TMO GROSS % | MTW FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.24B | $44.56B | 18.1% | — | -$15.3M | $6.29B |
| FY 2024 | $2.18B | $42.88B | 17.2% | — | $3.5M | $7.27B |
| FY 2023 | $2.23B | $42.86B | — | — | $63.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTW // BETA —
TMO // BETA 0.94